Health Canada drug identification number

DIN 02524163 — XOFLUZA 80 MG

XOFLUZA is a tablet of Baloxavir Marboxil marketed by HOFFMANN-LA ROCHE LIMITED. The full Baloxavir Marboxil monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02524163
Brand name
XOFLUZA
Active ingredient
Baloxavir Marboxil
Strength
80 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
HOFFMANN-LA ROCHE LIMITED
Health Canada status
MARKETED
Drug class
Cap-dependent endonuclease inhibitor (antiviral)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Baloxavir Marboxil products

DINBrandStrengthFormManufacturerStatus
02496364 XOFLUZA 20 MG TABLET HOFFMANN-LA ROCHE LIMITED MARKETED
02496372 XOFLUZA 40 MG TABLET HOFFMANN-LA ROCHE LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.